<DOC>
	<DOCNO>NCT01004783</DOCNO>
	<brief_summary>RATIONALE : Studying sample tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This clinical trial study biomarkers tumor tissue sample young patient low risk Wilms tumor .</brief_summary>
	<brief_title>Biomarkers Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors</brief_title>
	<detailed_description>OBJECTIVES : - To validate utility CUGBP2 , HMGA2 , MEIS2 mRNA expression 11p15 methylation define population pediatric patient low risk Wilms tumor ( VLRWT ) virtually risk relapse . - To validate utility WT-1 mutation 11p15 loss heterozygosity analysis determine population VLRWT high risk relapse treat chemotherapy . - To validate utility NFYA , STRA6 , TOB2 , PDCD4 , SP3 mRNA expression predict relapse VLRWT . - To investigate feasibility broaden definition VLRWT analysis stage I II epithelial differentiate tumor register clinical trial COG-Q9401 ( NWTS-5 ) CUGBP2 , HMGA2 , MEIS2 , 11p15 methylation . OUTLINE : Previously bank tumor tissue sample analyze mRNA expression CUGBP2 , HMGA2 , MEIS2 via reverse-transcriptase ( RT ) -PCR classified loss heterozygosity ( LOH ) , loss imprinting , neither via 11p15 analysis . Samples also analyze WT-1 mutation via quantitative PCR 11p LOH use 11p15 methylation analysis expression NFYA , STRA6 , TOB2 , PDCD4 , SP3 via quantitative RT-PCR</detailed_description>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Wilms Tumor</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Meets 1 follow criterion : Patient low risk Wilms tumor register clinical trial COGAREN03B2 Patient stage I II epithelial tubular differentiate Wilms tumor register clinical trial COGQ9401 ( NWTS5 ) PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not Specified</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>stage I Wilms tumor</keyword>
	<keyword>stage II Wilms tumor</keyword>
	<keyword>epithelial predominant Wilms tumor</keyword>
</DOC>